학술논문
526 - An ADAM17-Binding Antibody (MEDI-1) Enhances Proliferation of NK Cells from Multiple Myeloma Patients and Improves Killing with a B7-H3 Tri-Specific Killer Engager (TriKE)
Document Type
Abstract
Author
Source
In Transplantation and Cellular Therapy February 2023 29(2) Supplement:S393-S394
Subject
Language
ISSN
2666-6367